Biocon is currently trading at Rs. 372.40, up by 8.50 points or 2.34% from its previous closing of Rs. 363.90 on the BSE.

The scrip opened at Rs. 363.00 and has touched a high and low of Rs. 373.95 and Rs. 356.05 respectively. So far 109426 shares were traded on the counter.

The BSE group ‘A’ stock of face value Rs. 5 has touched a 52 week high of Rs. 456.00 on 21-Jan-2021 and a 52 week low of Rs. 314.90 on 25-Oct-2021.

Last one week high and low of the scrip stood at Rs. 373.95 and Rs. 347.10 respectively. The current market cap of the company is Rs. 44692.34 crore. Biocon

The promoters holding in the company stood at 60.64%, while Institutions and Non-Institutions held 23.37% and 15.99% respectively.

Biocon has reported a fall of 22.73% in its net profit at Rs 25.50 crore for the quarter ended December 31, 2021 as compared to Rs 33 crore for the same quarter in the previous year. However, total income of the company increased by 4.06% at Rs 509.70 crore for Q3FY22 as compared Rs 489.80 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a rise of 17.68% in its net profit at Rs 219.60 crore for the quarter ended December 31, 2021 as compared to Rs 186.60 crore for the same quarter in the previous year. Total income of the company increased by 17.88% at Rs 2222.50 crore for Q3FY22 as compared Rs 1885.30 crore for the corresponding quarter previous year.